Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

WASHINGTON, DC / ACCESS Newswire / July 15, 2025 /FairWinds Partners, the world's leading domain name strategy consultancy, ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

“My upcoming public hearing with Sen. (James) Skoufis will be an opportunity for PPL to speak to their leadership’s decisions ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Even as Apple faces mounting challenges — from AI stumbles to fading product innovation — the 64-year-old chief executive retains firm control.

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

The e-commerce giant has been working on an overhaul for the past several months without conducting any broad layoffs as part of its reorganization.

Amazon AMZN.O said on Friday its healthcare business will be divided into six new units as part of a restructuring effort, in a move that comes after recent top health executive departures. The ...